explore -WSS

explore

author：entertainment 2025-09-03 09:20:59 - browse：71844

James Fanale, the former CEO and president of Care New England, and his wife Deb (left) on their front porch. -- health coverage from STAT — Courtesy Ryan Pickering

PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road Race — walking up the hills, running down them — for seven miles. Fellow runners encouraged him to “keep trying” whenever he slowed down. But they couldn’t have known — along with most of the people in Fanale’s professional orbit — that he was battling Stage 4 lung cancer.

“Many times, I wanted to say ‘Listen buddy, you don’t know what I’ve got in me,’” Fanale recalled recently with a chuckle.

In December 2022, on the day Fanale retired as president and CEO of Care New England, he shared his diagnosis with a Globe reporter but requested it be kept private. He was handing the reins to new CEO Dr. Michael Wagner after six years leading the second largest health care system in Rhode Island.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Colorectal cancer study finds potential in overlooked immune cell

focus

WSS

3 questions for the future of Biden's cancer moonshot

Food makers to regulators: Ultra

Liquid biopsy for lung cancer is launched by Delfi

FDA authorizes Novavax’s updated Covid

Histogen: Failed biotech offers rare public look inside

New weight loss drugs vying to be the next Wegovy or Mounjaro

hotspot

explore

Wikipedia

Bright Health sells Medicare Advantage business to Molina

FDA authorizes Novavax’s updated Covid

Wildfire smoke exposes gaps in outdoor worker protections

Food makers to regulators: Ultra

Novavax promises a turnaround & Lilly roils the obesity market

VC firm General Catalyst wants to buy a health system

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves updated Covid vaccines

Anesthesiologist group: stop taking Ozempic before surgery

Food makers tried to stack nutrition panel with preferred experts

focus

The future of health care in the House

How to make the FDA’s new prescription one

FDA proposes changes to key medical devices approval pathway

What to make of Biden’s latest efforts on cancer research

Generate Biomedicines machine learning biotech raises $273M

Will the IRA bring competition to the biologics market?

hotspot

focus

knowledge

entertainment